Status:
TERMINATED
Impact of tDCS on Emotional Processing in Healthy Subjects.
Lead Sponsor:
Hôpital le Vinatier
Conditions:
Transcranial Direct Current Stimulation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The dorsolateral prefrontal cortex (DLPFC) plays a key part in emotional processing and regulation. Emotions continually influence other cognitive functions such as attentional resources .Emotions al...
Detailed Description
To study the modulation of the DLPFC (left and right) by tDCS (anode, cathode and placebo) on the processing of emotions and the impact on attentional resources, and physiological responses, subjects ...
Eligibility Criteria
Inclusion
- Men and women aged between 18 and 65 years
- Written given consent
Exclusion
- Psychiatric disorder
- Refusal from the subject
- Addiction except for tobacco addiction
- Ocular disease (except from refraction disorders), neurologic or cardiac disease.
- Neuroleptic or anticonvulsivant treatment
- presence of a specific contraindication for tDCS (e.g., personal history of epilepsy, metallic head implant, cardiac pacemaker)
- pregnant or breastfeeding women
Key Trial Info
Start Date :
July 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03286075
Start Date
July 16 2018
End Date
February 12 2019
Last Update
October 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ch Le Vinatier
Lyon, Auvergne-Rhône-Alpes, France, 69678